Larimar Therapeutics Inc (LRMR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Carole S. Ben-Maimon
Employees:
38
THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
844-511-9056

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases.

Data derived from most recent annual or quarterly report
Market Cap 227.756 Million Shares Outstanding17.71 Million Avg 30-day Volume 37.166 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 25.87 / 7.0 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from LRMR instead.

View recent insider trading info

Funds Holding LRMR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LRMR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT HIF, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • Director
  • 10% Owner
  • * DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
5,830,249 2021-06-30 2

HAMILTON THOMAS EDWARD

  • Director
349,563 2021-06-30 2

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • 10% Owner
  • * DIRECTOR BY DEPUTIZATION* DIRECTOR BY DEPUTIZATION
8,300 2021-05-12 2

LEFF JONATHAN S

  • Director
8,300 2021-05-12 1

THOMAS FRANK E

  • Director
8,300 2021-05-12 1

BARRETT PETER

  • Director
8,300 2021-05-12 1

TRUITT JOSEPH

  • Director
8,300 2021-05-12 1

DANIEL THOMAS O

  • Director
8,300 2021-05-12 1

CELANO MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-19 1

BEN-MAIMON CAROLE PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-19 1

CHONDRIAL THERAPEUTICS HOLDINGS, LLC

  • 10% Owner
No longer subject to file 2020-06-26 0

LAMATTINA JOHN L

  • Director
0 2019-06-26 0

PEREZ ROBERT J

  • Director
0 2019-06-26 0

MCDONOUGH CAMERON GEOFFREY

  • Director
0 2019-06-26 0

EVERETT WENDY

  • Director
0 2019-06-26 0

SINGHAL PRIYA HEAD OF RESEARCH & DEVELOPMENT

  • Officer
0 2019-04-02 0

ALLEN PATRICIA L CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-22 0

KIM DENNIS D CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-22 0

HATFIELD JEFFREY S. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-01-22 0

MCVEIGH BRIAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-01-22 0

ATLAS VENTURE FUND VII L P

ATLAS VENTURE ASSOCIATES VII, L.P.

ATLAS VENTURE ASSOCIATES VII, INC.

  • 10% Owner
No longer subject to file 2018-06-29 0

HUGHES THOMAS E. SEE REMARKS

  • Officer
  • Director
125,247 2018-06-28 0

BOOTH BRUCE

  • Director
  • 10% Owner
0 2018-01-03 0

HELLER FRANCES K

  • Director
47,961 2017-10-13 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2016-07-20 0

SECOR ALICIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2016-03-31 0

LOUSTAU PATRICK PRESIDENT

  • Officer
0 2016-03-31 0

STARR KEVIN P

  • Director
580,694 2015-09-24 0

GOLDBERG AVI Y.

  • Director
53,734 2015-09-18 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2015-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 22:15:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 21:45:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 21:15:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 20:45:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 20:15:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 19:45:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 19:15:03 UTC -0.7564 0.8264 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 18:45:03 UTC -0.9097 0.9797 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 18:15:03 UTC -0.9097 0.9797 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 17:45:03 UTC -0.9097 0.9797 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 17:15:03 UTC -0.9097 0.9797 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 16:45:04 UTC -0.8927 0.9627 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 16:15:03 UTC -0.8927 0.9627 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 15:45:03 UTC -0.8927 0.9627 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 15:15:03 UTC -0.8927 0.9627 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 14:45:03 UTC -0.7438 0.8138 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 14:15:05 UTC -0.7438 0.8138 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 13:45:03 UTC -0.7438 0.8138 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 13:15:03 UTC -0.7438 0.8138 700000
LARIMAR THERAPEUTICS INC LRMR 2021-10-26 12:45:03 UTC -0.7438 0.8138 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments